on 05 Dec 2024
Last Applicant/ Owned by
London EC4N 6EU
GB
Serial Number
79186459 filed on 23rd Feb 2016
Registration Number
5308724 registered on 17th Oct 2017
Correspondent Address
Matthew J. Smith
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Research and development in the field of gene therapy; Research and development in the field of ex-vivo autologous gene therapy; Information, advisory and consulting services in the field of gene therapy Medical services, namely, ex-vivo autologous gene therapy Gene therapy products, namely, genetically engineered tissues for transplant purposes; Stem cells for medical purposes
Medical services, namely, ex-vivo autologous gene therapy
N/A
N/A
Research and development in the field of gene therapy; Research and development in the field of ex-vivo autologous gene therapy; Information, advisory and consulting services in the field of gene therapy
N/A
N/A
Gene therapy products, namely, genetically engineered tissues for transplant purposes; Stem cells for medical purposes
N/A
N/A
No 79186459
No Service Mark
No 086522-75928
No
No
No
No
Yes
Yes
No
No
Status Date | Action Taken |
---|---|
05th Dec 2024 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED |
05th Dec 2024 | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. |
25th Nov 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
15th Apr 2024 | TEAS SECTION 71 & 15 RECEIVED |
17th Oct 2022 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
02th Oct 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
27th Nov 2020 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
30th Aug 2018 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
23rd Feb 2018 | FINAL DECISION TRANSACTION PROCESSED BY IB |
25th Jan 2018 | FINAL DISPOSITION NOTICE SENT TO IB |